1. Home
  2. FINW vs MDWD Comparison

FINW vs MDWD Comparison

Compare FINW & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinWise Bancorp

FINW

FinWise Bancorp

N/A

Current Price

$17.35

Market Cap

245.2M

Sector

Finance

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.19

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINW
MDWD
Founded
1999
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Commercial Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.2M
224.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
FINW
MDWD
Price
$17.35
$17.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$37.50
AVG Volume (30 Days)
31.3K
137.5K
Earning Date
01-29-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
21.51
N/A
EPS
1.13
N/A
Revenue
$92,093,000.00
$20,932,000.00
Revenue This Year
$92.23
$6.97
Revenue Next Year
$23.28
$23.59
P/E Ratio
$15.59
N/A
Revenue Growth
31.91
6.15
52 Week Low
$13.49
$14.14
52 Week High
$22.49
$22.51

Technical Indicators

Market Signals
Indicator
FINW
MDWD
Relative Strength Index (RSI) 43.84 43.13
Support Level $17.55 $17.01
Resistance Level $19.04 $18.48
Average True Range (ATR) 0.59 0.78
MACD -0.06 0.02
Stochastic Oscillator 6.84 39.31

Price Performance

Historical Comparison
FINW
MDWD

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: